{"transactions":[{"id":2498019,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":133158,"kind":"person","name":"HAN QUEENA","position":1,"cik":"0001638986","reported_name":"HAN QUEENA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & HR"}}],"security":"Stock Option","published_at":"2021-11-23T16:10:37.000Z","date":"2021-11-19","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":35000,"derivative":{"exercise_price":12.67,"exercise_date":"2022-11-19","expiration_date":"2031-11-19","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-21-066401","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638986/000120919121066401/doc4.xml","form_type":"4"}},{"id":3041202,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":133158,"kind":"person","name":"HAN QUEENA","position":1,"cik":"0001638986","reported_name":"HAN QUEENA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & HR"}}],"security":"Stock Option","published_at":"2020-09-02T11:33:11.000Z","date":"2020-09-01","kind":"exercise","acquired":false,"shares":27692,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":4.16,"exercise_date":"2019-05-08","expiration_date":"2028-05-08","underlying":"Common Stock","underlying_shares":27692},"source":{"system":"sec-edgar","filing":"0001209191-20-049028","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1638986/000120919120049028/doc4.xml","form_type":"4"}},{"id":3041201,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":133158,"kind":"person","name":"HAN QUEENA","position":1,"cik":"0001638986","reported_name":"HAN QUEENA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & HR"}}],"security":"Stock Option","published_at":"2020-09-02T11:33:11.000Z","date":"2020-09-01","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":4.24,"exercise_date":"2018-06-19","expiration_date":"2027-06-19","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-20-049028","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1638986/000120919120049028/doc4.xml","form_type":"4"}},{"id":3041200,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":133158,"kind":"person","name":"HAN QUEENA","position":1,"cik":"0001638986","reported_name":"HAN QUEENA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & HR"}}],"security":"Common Stock","published_at":"2020-09-02T11:33:11.000Z","date":"2020-09-01","kind":"exercise","acquired":true,"shares":27692,"price":4.16,"value":115198.72,"ownership":{"direct":true},"balance_after":57692,"source":{"system":"sec-edgar","filing":"0001209191-20-049028","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1638986/000120919120049028/doc4.xml","form_type":"4"}},{"id":3041199,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":133158,"kind":"person","name":"HAN QUEENA","position":1,"cik":"0001638986","reported_name":"HAN QUEENA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & HR"}}],"security":"Common Stock","published_at":"2020-09-02T11:33:11.000Z","date":"2020-09-01","kind":"exercise","acquired":true,"shares":30000,"price":4.24,"value":127200.0,"ownership":{"direct":true},"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001209191-20-049028","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638986/000120919120049028/doc4.xml","form_type":"4"}},{"id":3046368,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":133158,"kind":"person","name":"HAN QUEENA","position":1,"cik":"0001638986","reported_name":"HAN QUEENA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & HR"}}],"security":"Stock Options","published_at":"2020-08-26T13:35:17.000Z","date":"2020-08-24","kind":"exercise","acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":5.26,"exercise_date":"2020-01-04","expiration_date":"2029-01-04","underlying":"Common Stocks","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-20-048337","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1638986/000120919120048337/doc4.xml","form_type":"4"}},{"id":3046367,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":133158,"kind":"person","name":"HAN QUEENA","position":1,"cik":"0001638986","reported_name":"HAN QUEENA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & HR"}}],"security":"Stock Options","published_at":"2020-08-26T13:35:17.000Z","date":"2020-08-24","kind":"exercise","acquired":false,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":4.14,"exercise_date":"2019-12-07","expiration_date":"2028-12-07","underlying":"Common Stocks","underlying_shares":3333},"source":{"system":"sec-edgar","filing":"0001209191-20-048337","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1638986/000120919120048337/doc4.xml","form_type":"4"}},{"id":3046366,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":133158,"kind":"person","name":"HAN QUEENA","position":1,"cik":"0001638986","reported_name":"HAN QUEENA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & HR"}}],"security":"Stock Options","published_at":"2020-08-26T13:35:17.000Z","date":"2020-08-24","kind":"exercise","acquired":false,"shares":12308,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":4.16,"exercise_date":"2019-05-08","expiration_date":"2028-05-08","underlying":"Common Stocks","underlying_shares":12308},"source":{"system":"sec-edgar","filing":"0001209191-20-048337","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1638986/000120919120048337/doc4.xml","form_type":"4"}},{"id":3046365,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":133158,"kind":"person","name":"HAN QUEENA","position":1,"cik":"0001638986","reported_name":"HAN QUEENA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & HR"}}],"security":"Stock Options","published_at":"2020-08-26T13:35:17.000Z","date":"2020-08-24","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":15,"exercise_date":"2013-12-12","expiration_date":"2022-12-12","underlying":"Common Stocks","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-20-048337","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1638986/000120919120048337/doc4.xml","form_type":"4"}},{"id":3046364,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":133158,"kind":"person","name":"HAN QUEENA","position":1,"cik":"0001638986","reported_name":"HAN QUEENA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & HR"}}],"security":"Stock options","published_at":"2020-08-26T13:35:17.000Z","date":"2020-08-24","kind":"exercise","acquired":false,"shares":18700,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":7.5,"exercise_date":"2012-02-28","expiration_date":"2021-02-28","underlying":"Common Stocks","underlying_shares":18700},"source":{"system":"sec-edgar","filing":"0001209191-20-048337","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1638986/000120919120048337/doc4.xml","form_type":"4"}},{"id":3046363,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":133158,"kind":"person","name":"HAN QUEENA","position":1,"cik":"0001638986","reported_name":"HAN QUEENA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & HR"}}],"security":"Common Shares","published_at":"2020-08-26T13:35:17.000Z","date":"2020-08-24","kind":"sale","acquired":false,"shares":12500,"price":19.6543,"value":245678.75,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-048337","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1638986/000120919120048337/doc4.xml","form_type":"4"}},{"id":3046362,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":133158,"kind":"person","name":"HAN QUEENA","position":1,"cik":"0001638986","reported_name":"HAN QUEENA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & HR"}}],"security":"Common Shares","published_at":"2020-08-26T13:35:17.000Z","date":"2020-08-24","kind":"exercise","acquired":true,"shares":12500,"price":5.26,"value":65750.0,"ownership":{"direct":true},"balance_after":12500,"source":{"system":"sec-edgar","filing":"0001209191-20-048337","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1638986/000120919120048337/doc4.xml","form_type":"4"}},{"id":3046361,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":133158,"kind":"person","name":"HAN QUEENA","position":1,"cik":"0001638986","reported_name":"HAN QUEENA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & HR"}}],"security":"Common Shares","published_at":"2020-08-26T13:35:17.000Z","date":"2020-08-24","kind":"sale","acquired":false,"shares":3333,"price":19.6543,"value":65507.7819,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-048337","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1638986/000120919120048337/doc4.xml","form_type":"4"}},{"id":3046360,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":133158,"kind":"person","name":"HAN QUEENA","position":1,"cik":"0001638986","reported_name":"HAN QUEENA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & HR"}}],"security":"Common Shares","published_at":"2020-08-26T13:35:17.000Z","date":"2020-08-24","kind":"exercise","acquired":true,"shares":3333,"price":4.14,"value":13798.62,"ownership":{"direct":true},"balance_after":3333,"source":{"system":"sec-edgar","filing":"0001209191-20-048337","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1638986/000120919120048337/doc4.xml","form_type":"4"}},{"id":3046359,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":133158,"kind":"person","name":"HAN QUEENA","position":1,"cik":"0001638986","reported_name":"HAN QUEENA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & HR"}}],"security":"Common Shares","published_at":"2020-08-26T13:35:17.000Z","date":"2020-08-24","kind":"sale","acquired":false,"shares":12308,"price":19.6543,"value":241905.1244,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-048337","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1638986/000120919120048337/doc4.xml","form_type":"4"}},{"id":3046358,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":133158,"kind":"person","name":"HAN QUEENA","position":1,"cik":"0001638986","reported_name":"HAN QUEENA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & HR"}}],"security":"Common Shares","published_at":"2020-08-26T13:35:17.000Z","date":"2020-08-24","kind":"exercise","acquired":true,"shares":12308,"price":4.16,"value":51201.28,"ownership":{"direct":true},"balance_after":12308,"source":{"system":"sec-edgar","filing":"0001209191-20-048337","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1638986/000120919120048337/doc4.xml","form_type":"4"}},{"id":3046357,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":133158,"kind":"person","name":"HAN QUEENA","position":1,"cik":"0001638986","reported_name":"HAN QUEENA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & HR"}}],"security":"Common Shares","published_at":"2020-08-26T13:35:17.000Z","date":"2020-08-24","kind":"sale","acquired":false,"shares":5000,"price":19.6543,"value":98271.5,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-048337","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1638986/000120919120048337/doc4.xml","form_type":"4"}},{"id":3046356,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":133158,"kind":"person","name":"HAN QUEENA","position":1,"cik":"0001638986","reported_name":"HAN QUEENA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & HR"}}],"security":"Common Shares","published_at":"2020-08-26T13:35:17.000Z","date":"2020-08-24","kind":"exercise","acquired":true,"shares":5000,"price":15,"value":75000.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001209191-20-048337","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1638986/000120919120048337/doc4.xml","form_type":"4"}},{"id":3046355,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":133158,"kind":"person","name":"HAN QUEENA","position":1,"cik":"0001638986","reported_name":"HAN QUEENA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & HR"}}],"security":"Common Shares","published_at":"2020-08-26T13:35:17.000Z","date":"2020-08-24","kind":"sale","acquired":false,"shares":18700,"price":19.6543,"value":367535.41,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-048337","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1638986/000120919120048337/doc4.xml","form_type":"4"}},{"id":3046354,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":133158,"kind":"person","name":"HAN QUEENA","position":1,"cik":"0001638986","reported_name":"HAN QUEENA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & HR"}}],"security":"Common Shares","published_at":"2020-08-26T13:35:17.000Z","date":"2020-08-24","kind":"exercise","acquired":true,"shares":18700,"price":7.5,"value":140250.0,"ownership":{"direct":true},"balance_after":18700,"source":{"system":"sec-edgar","filing":"0001209191-20-048337","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638986/000120919120048337/doc4.xml","form_type":"4"}},{"id":3049911,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":133158,"kind":"person","name":"HAN QUEENA","position":1,"cik":"0001638986","reported_name":"HAN QUEENA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & HR"}}],"security":"Stock options","published_at":"2020-08-21T14:56:00.000Z","date":"2020-08-17","kind":"exercise","acquired":false,"shares":1300,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":7.5,"exercise_date":"2012-02-28","expiration_date":"2021-02-28","underlying":"Common Stocks","underlying_shares":1300},"source":{"system":"sec-edgar","filing":"0001209191-20-047889","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1638986/000120919120047889/doc4.xml","form_type":"4"}},{"id":3049910,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":133158,"kind":"person","name":"HAN QUEENA","position":1,"cik":"0001638986","reported_name":"HAN QUEENA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & HR"}}],"security":"Common Stock","published_at":"2020-08-21T14:56:00.000Z","date":"2020-08-17","kind":"sale","acquired":false,"shares":1300,"price":19.3,"value":25090.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-047889","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1638986/000120919120047889/doc4.xml","form_type":"4"}},{"id":3049909,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":133158,"kind":"person","name":"HAN QUEENA","position":1,"cik":"0001638986","reported_name":"HAN QUEENA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & HR"}}],"security":"Common Shares","published_at":"2020-08-21T14:56:00.000Z","date":"2020-08-17","kind":"exercise","acquired":true,"shares":1300,"price":7.5,"value":9750.0,"ownership":{"direct":true},"balance_after":1300,"source":{"system":"sec-edgar","filing":"0001209191-20-047889","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638986/000120919120047889/doc4.xml","form_type":"4"}},{"id":3376429,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":133158,"kind":"person","name":"HAN QUEENA","position":1,"cik":"0001638986","reported_name":"HAN QUEENA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & HR"}}],"security":"Stock Option","published_at":"2019-11-08T15:06:44.000Z","date":"2019-11-06","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":75000,"derivative":{"exercise_price":10.36,"exercise_date":"2020-11-05","expiration_date":"2029-11-06","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-19-055794","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638986/000120919119055794/doc4.xml","form_type":"4"}},{"id":3619112,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":133158,"kind":"person","name":"HAN QUEENA","position":1,"cik":"0001638986","reported_name":"HAN QUEENA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & HR"}}],"security":"Stock Option","published_at":"2019-03-04T16:48:47.000Z","date":"2019-01-04","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25000,"derivative":{"exercise_price":5.26,"exercise_date":"2020-01-04","expiration_date":"2029-01-04","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-19-015691","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638986/000120919119015691/doc4.xml","form_type":"4"}},{"id":3886133,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":133158,"kind":"person","name":"HAN QUEENA","position":1,"cik":"0001638986","reported_name":"HAN QUEENA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & HR"}}],"security":"Stock Option","published_at":"2018-06-21T16:48:41.000Z","date":"2018-05-08","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":40000,"derivative":{"exercise_price":4.16,"exercise_date":"2019-05-08","expiration_date":"2028-05-08","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-18-038967","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638986/000120919118038967/doc4a.xml","form_type":"4/A","original_submission_date":"2018-05-11"}},{"id":3937123,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":133158,"kind":"person","name":"HAN QUEENA","position":1,"cik":"0001638986","reported_name":"HAN QUEENA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & HR"}}],"security":"Stock Option","published_at":"2018-05-11T11:39:06.000Z","date":"2018-05-08","kind":"exercise","acquired":true,"shares":40000,"price":4.16,"value":166400.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On September 14, 2016 (the Grant Date) Fabrizio Bonanni was granted nonstatutory stock options (the Options) under the Company's 2015 Equity Incentive Plan to purcahse shares of the Company's Common Stock (the Shares) at an exercise price equal to the closing sales price of the Shares on the Grant Date as quoted by the Nasdaq Stock Market, with an expiry of ten years from the Grant Date. Half of the Options vest on December 20, 2016 and another half of the Options vest on June 20, 2017."}],"balance_after":40000,"derivative":{"exercise_price":4.16,"exercise_date":"2019-05-08","expiration_date":"2028-05-08","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-18-029438","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638986/000120919118029438/doc4.xml","form_type":"4"}},{"id":3983042,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":133158,"kind":"person","name":"HAN QUEENA","position":1,"cik":"0001638986","reported_name":"HAN QUEENA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & HR"}}],"security":"Stock options","published_at":"2018-03-26T15:39:48.000Z","date":"2018-03-23","kind":"exercise","acquired":false,"shares":8201,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":2.5,"exercise_date":"2009-04-22","expiration_date":"2018-04-23","underlying":"Common Stock","underlying_shares":8201},"source":{"system":"sec-edgar","filing":"0001209191-18-021609","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1638986/000120919118021609/doc4.xml","form_type":"4"}},{"id":3983041,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":133158,"kind":"person","name":"HAN QUEENA","position":1,"cik":"0001638986","reported_name":"HAN QUEENA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & HR"}}],"security":"Stock options","published_at":"2018-03-26T15:39:48.000Z","date":"2018-03-22","kind":"exercise","acquired":false,"shares":62200,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":2.5,"exercise_date":"2009-04-22","expiration_date":"2018-04-23","underlying":"Common Stock","underlying_shares":62200},"source":{"system":"sec-edgar","filing":"0001209191-18-021609","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1638986/000120919118021609/doc4.xml","form_type":"4"}},{"id":3983040,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":133158,"kind":"person","name":"HAN QUEENA","position":1,"cik":"0001638986","reported_name":"HAN QUEENA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & HR"}}],"security":"Stock options","published_at":"2018-03-26T15:39:48.000Z","date":"2018-03-21","kind":"exercise","acquired":false,"shares":9599,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":2.5,"exercise_date":"2009-04-22","expiration_date":"2018-04-23","underlying":"Common Stocks","underlying_shares":9599},"source":{"system":"sec-edgar","filing":"0001209191-18-021609","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1638986/000120919118021609/doc4.xml","form_type":"4"}},{"id":3983039,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":133158,"kind":"person","name":"HAN QUEENA","position":1,"cik":"0001638986","reported_name":"HAN QUEENA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & HR"}}],"security":"Common Stock","published_at":"2018-03-26T15:39:48.000Z","date":"2018-03-23","kind":"sale","acquired":false,"shares":8201,"price":4.75,"value":38954.75,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-021609","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1638986/000120919118021609/doc4.xml","form_type":"4"}},{"id":3983038,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":133158,"kind":"person","name":"HAN QUEENA","position":1,"cik":"0001638986","reported_name":"HAN QUEENA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & HR"}}],"security":"Common Stock","published_at":"2018-03-26T15:39:48.000Z","date":"2018-03-23","kind":"exercise","acquired":true,"shares":8201,"price":2.5,"value":20502.5,"ownership":{"direct":true},"balance_after":8201,"source":{"system":"sec-edgar","filing":"0001209191-18-021609","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1638986/000120919118021609/doc4.xml","form_type":"4"}},{"id":3983037,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":133158,"kind":"person","name":"HAN QUEENA","position":1,"cik":"0001638986","reported_name":"HAN QUEENA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & HR"}}],"security":"Common Stock","published_at":"2018-03-26T15:39:48.000Z","date":"2018-03-22","kind":"sale","acquired":false,"shares":62200,"price":4.7614,"value":296159.08,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.75 to $4.77, inclusive. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-021609","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1638986/000120919118021609/doc4.xml","form_type":"4"}},{"id":3983036,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":133158,"kind":"person","name":"HAN QUEENA","position":1,"cik":"0001638986","reported_name":"HAN QUEENA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & HR"}}],"security":"Common Stock","published_at":"2018-03-26T15:39:48.000Z","date":"2018-03-22","kind":"exercise","acquired":true,"shares":62200,"price":2.5,"value":155500.0,"ownership":{"direct":true},"balance_after":62200,"source":{"system":"sec-edgar","filing":"0001209191-18-021609","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1638986/000120919118021609/doc4.xml","form_type":"4"}},{"id":3983035,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":133158,"kind":"person","name":"HAN QUEENA","position":1,"cik":"0001638986","reported_name":"HAN QUEENA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & HR"}}],"security":"Common Stock","published_at":"2018-03-26T15:39:48.000Z","date":"2018-03-21","kind":"sale","acquired":false,"shares":9599,"price":4.4783,"value":42987.2017,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.75 to $4.85, inclusive. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-021609","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1638986/000120919118021609/doc4.xml","form_type":"4"}},{"id":3983034,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":133158,"kind":"person","name":"HAN QUEENA","position":1,"cik":"0001638986","reported_name":"HAN QUEENA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & HR"}}],"security":"Common Stock","published_at":"2018-03-26T15:39:48.000Z","date":"2018-03-21","kind":"exercise","acquired":true,"shares":9599,"price":2.5,"value":23997.5,"ownership":{"direct":true},"balance_after":9599,"source":{"system":"sec-edgar","filing":"0001209191-18-021609","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638986/000120919118021609/doc4.xml","form_type":"4"}},{"id":4273534,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":133158,"kind":"person","name":"HAN QUEENA","position":1,"cik":"0001638986","reported_name":"HAN QUEENA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & HR"}}],"security":"Stock Option","published_at":"2017-06-23T14:51:58.000Z","date":"2017-06-19","kind":"exercise","acquired":true,"shares":30000,"price":4.24,"value":127200.0,"ownership":{"direct":true},"balance_after":50000,"derivative":{"exercise_price":4.24,"exercise_date":"2018-06-19","expiration_date":"2027-06-19","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-17-041616","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638986/000120919117041616/doc4a.xml","form_type":"4/A","original_submission_date":"2017-06-23"}},{"id":4273533,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":133158,"kind":"person","name":"HAN QUEENA","position":1,"cik":"0001638986","reported_name":"HAN QUEENA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & HR"}}],"security":"Stock Option","published_at":"2017-06-23T14:12:38.000Z","date":"2017-06-19","kind":"exercise","acquired":true,"shares":30000,"price":4.24,"value":127200.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On September 14, 2016 (the Grant Date) Fabrizio Bonanni was granted nonstatutory stock options (the Options) under the Company's 2015 Equity Incentive Plan to purcahse shares of the Company's Common Stock (the Shares) at an exercise price equal to the closing sales price of the Shares on the Grant Date as quoted by the Nasdaq Stock Market, with an expiry of ten years from the Grant Date. Half of the Options vest on December 20, 2016 and another half of the Options vest on June 20, 2017."}],"balance_after":50000,"derivative":{"exercise_price":4.24,"exercise_date":"2018-06-19","expiration_date":"2027-06-19","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-17-041606","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638986/000120919117041606/doc4.xml","form_type":"4"}},{"id":4550619,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":133158,"kind":"person","name":"HAN QUEENA","position":1,"cik":"0001638986","reported_name":"HAN QUEENA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & HR"}}],"security":"Stock options","published_at":"2016-11-17T16:01:08.000Z","date":"2016-09-08","kind":"exercise","acquired":false,"shares":19573,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.74,"exercise_date":"2007-12-10","expiration_date":"2016-12-09","underlying":"Common Stocks","underlying_shares":19573},"source":{"system":"sec-edgar","filing":"0001209191-16-150817","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1638986/000120919116150817/doc4.xml","form_type":"4"}},{"id":4550618,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":133158,"kind":"person","name":"HAN QUEENA","position":1,"cik":"0001638986","reported_name":"HAN QUEENA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & HR"}}],"security":"Common Stock","published_at":"2016-11-17T16:01:08.000Z","date":"2016-11-15","kind":"sale","acquired":false,"shares":19573,"price":15,"value":293595.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-16-150817","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1638986/000120919116150817/doc4.xml","form_type":"4"}},{"id":4550617,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":133158,"kind":"person","name":"HAN QUEENA","position":1,"cik":"0001638986","reported_name":"HAN QUEENA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & HR"}}],"security":"Common Shares","published_at":"2016-11-17T16:01:08.000Z","date":"2016-11-15","kind":"exercise","acquired":true,"shares":19573,"price":0.74,"value":14484.02,"ownership":{"direct":true},"balance_after":19573,"source":{"system":"sec-edgar","filing":"0001209191-16-150817","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638986/000120919116150817/doc4.xml","form_type":"4"}},{"id":4605865,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":133158,"kind":"person","name":"HAN QUEENA","position":1,"cik":"0001638986","reported_name":"HAN QUEENA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & HR"}}],"security":"Stock options","published_at":"2016-09-12T15:45:12.000Z","date":"2016-09-08","kind":"exercise","acquired":false,"shares":427,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":19573,"derivative":{"exercise_price":0.77,"exercise_date":"2007-12-10","expiration_date":"2016-12-09","underlying":"Common Stocks","underlying_shares":427},"source":{"system":"sec-edgar","filing":"0001209191-16-140913","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1638986/000120919116140913/doc4.xml","form_type":"4"}},{"id":4605864,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":133158,"kind":"person","name":"HAN QUEENA","position":1,"cik":"0001638986","reported_name":"HAN QUEENA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & HR"}}],"security":"Common Stock","published_at":"2016-09-12T15:45:12.000Z","date":"2016-09-08","kind":"sale","acquired":false,"shares":427,"price":15,"value":6405.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-16-140913","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1638986/000120919116140913/doc4.xml","form_type":"4"}},{"id":4605863,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":133158,"kind":"person","name":"HAN QUEENA","position":1,"cik":"0001638986","reported_name":"HAN QUEENA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & HR"}}],"security":"Common Shares","published_at":"2016-09-12T15:45:12.000Z","date":"2016-09-08","kind":"exercise","acquired":true,"shares":427,"price":0.77,"value":328.79,"ownership":{"direct":true},"balance_after":427,"source":{"system":"sec-edgar","filing":"0001209191-16-140913","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638986/000120919116140913/doc4.xml","form_type":"4"}}]}